Pre-operative sterilisation of the bowel

Active Ingredient: Neomycin

Indication for Neomycin

Population group: only adolescents (12 years - 18 years old)

Neomycin is indicated for pre-operative sterilisation of the bowel.

For this indication, competent medicine agencies globally authorize below treatments:

6 g in 6 divided doses daily

Route of admnistration

Oral

Defined daily dose

6 g

Dosage regimen

1 g 6 time(s) per day every day for 3 day(s)

Detailed description

Children over 12 years: 1gr every 4 hours for 2 or 3 days before the operation.

Active ingredient

Neomycin

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

Read more about Neomycin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.